{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T22:55:40Z","timestamp":1767826540851,"version":"3.49.0"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,3,19]],"date-time":"2015-03-19T00:00:00Z","timestamp":1426723200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Altern Med"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12906-015-0564-0","type":"journal-article","created":{"date-parts":[[2015,3,18]],"date-time":"2015-03-18T16:27:01Z","timestamp":1426696021000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["A cleanroom sleeping environment\u2019s impact on markers of oxidative stress, immune dysregulation, and behavior in children with autism spectrum disorders"],"prefix":"10.1186","volume":"15","author":[{"given":"Scott","family":"Faber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory M","family":"Zinn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Boggess","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Fahrenholz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"II","given":"John C","family":"Kern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HM Skip","family":"Kingston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,3,19]]},"reference":[{"key":"564_CR1","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1136\/bmj.327.7413.488","volume":"327","author":"G Baird","year":"2003","unstructured":"Baird G, Cass H, Slonims V. Diagnosis of autism. BMJ. 2003;327:488\u201393.","journal-title":"BMJ"},{"issue":"3","key":"564_CR2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/mrdd.10029","volume":"8","author":"L Wing","year":"2002","unstructured":"Wing L, Potter D. The epidemiology of autistic spectrum disorders: is the prevalence rising? Ment Retard Dev Disabil Res Rev. 2002;8(3):151\u201361.","journal-title":"Ment Retard Dev Disabil Res Rev"},{"issue":"Suppl 2","key":"564_CR3","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1038\/sj.mp.4001162","volume":"7","author":"E Fombonne","year":"2002","unstructured":"Fombonne E. Epidemiologic trends in rates of autism. Mol Psychiatry. 2002;7 Suppl 2:S4\u20136.","journal-title":"Mol Psychiatry"},{"issue":"6","key":"564_CR4","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00787-002-0297-8","volume":"11","author":"T Charman","year":"2002","unstructured":"Charman T. The prevalence of autism spectrum disorders. Eur Child Adolesc Psychiatry. 2002;11(6):249\u201356.","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"4","key":"564_CR5","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1023\/A:1025054610557","volume":"33","author":"E Fombonne","year":"2003","unstructured":"Fombonne E. Epidemiological surveys of autism and other pervasive developmental disorders: an update. J Autism Dev Disord. 2003;33(4):365\u201382.","journal-title":"J Autism Dev Disord"},{"issue":"1","key":"564_CR6","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1001\/jama.289.1.87","volume":"289","author":"E Fombonne","year":"2003","unstructured":"Fombonne E. The prevalence of autism. J Am Med Assoc. 2003;289(1):87\u20139.","journal-title":"J Am Med Assoc"},{"issue":"1","key":"564_CR7","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1136\/adc.2004.062083","volume":"91","author":"JG Williams","year":"2006","unstructured":"Williams JG, Higgins JPT, Brayne CEG. Systematic review of prevalence studies of autism spectrum disorders. Arch Dis Child. 2006;91(1):8\u201315.","journal-title":"Arch Dis Child"},{"key":"564_CR8","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1192\/bjp.bp.108.059345","volume":"194","author":"S Baron-Cohen","year":"2009","unstructured":"Baron-Cohen S, Scott FJ, Allison C, Williams J, Bolton P, Matthews FE, et al. Prevalence of autism-spectrum conditions: UK school-based population study. Br J Psychiatry. 2009;194:500\u20139.","journal-title":"Br J Psychiatry"},{"issue":"4","key":"564_CR9","doi-asserted-by":"crossref","first-page":"e727","DOI":"10.1542\/peds.2009-1684","volume":"125","author":"Y Shen","year":"2010","unstructured":"Shen Y, Dies KA, Holm IA, Bridgemohan C, Sobeih MM, Caronna EB, et al. Clinical genetic testing for patients with autism spectrum disorders. Pediatrics. 2010;125(4):e727\u201335.","journal-title":"Pediatrics"},{"issue":"7304","key":"564_CR10","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nature09146","volume":"466","author":"D Pinto","year":"2010","unstructured":"Pinto D, Pagnamenta AT, Klei L, Anney R, Merico D, Regan R, et al. Function impact of global rare copy number varients. Nature. 2010;466(7304):368\u201372.","journal-title":"Nature"},{"issue":"7","key":"564_CR11","doi-asserted-by":"crossref","first-page":"a258","DOI":"10.1289\/ehp.1104285","volume":"120","author":"PJ Landrigan","year":"2012","unstructured":"Landrigan PJ, Lambertini L, Birnbaum LS. A research strategy to discover the environmental causes of autism and neurodevelopmental disabilities. Environ Health Perspect. 2012;120(7):a258\u201360.","journal-title":"Environ Health Perspect"},{"issue":"6","key":"564_CR12","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1289\/ehp.1307204","volume":"122","author":"M Vrijheid","year":"2014","unstructured":"Vrijheid M, Slama R, Robinson O, Chatzi L, Coen M, Hazel P, et al. The Human Early-Life Exposome (HELIX): project rationale and design. Environ Health Perspect. 2014;122(6):535\u201344.","journal-title":"Environ Health Perspect"},{"key":"564_CR13","volume-title":"Autism, brain, and environment","author":"R Lathe","year":"2006","unstructured":"Lathe R. Autism, brain, and environment. London: Jessica Kingsley Publishers; 2006."},{"issue":"2","key":"564_CR14","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.healthplace.2004.11.005","volume":"12","author":"RF Palmer","year":"2006","unstructured":"Palmer RF, Blanchard S, Stein Z, Mandell D, Miller C. Environmental mercury release, special education rates, and autism disorder: an ecological study of Texas. Health Place. 2006;12(2):203\u20139.","journal-title":"Health Place"},{"issue":"1","key":"564_CR15","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.healthplace.2008.02.001","volume":"15","author":"RF Palmer","year":"2009","unstructured":"Palmer RF, Blanchard S, Wood R. Proximity to point sources of environmental mercury release as a predictor of autism prevalence. Health Place. 2009;15(1):18\u201324.","journal-title":"Health Place"},{"issue":"10","key":"564_CR16","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1289\/ehp.10168","volume":"115","author":"EM Roberts","year":"2007","unstructured":"Roberts EM, English PB, Grether JK, Windham GC, Somberg L, Wolff C. Maternal residence near agricultural pesticide applications and autism spectrum disorders among children in the California Central Valley. Environ Health Perspect. 2007;115(10):1482\u20139.","journal-title":"Environ Health Perspect"},{"issue":"5","key":"564_CR17","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1542\/peds.108.5.1155","volume":"108","author":"J Bertrand","year":"2001","unstructured":"Bertrand J, Mars A, Boyle C, Bove F. Prevalence of autism in a United States population: the brick township, New Jersey, investigation. Pediatrics. 2001;108(5):1155\u201361.","journal-title":"Pediatrics"},{"issue":"1","key":"564_CR18","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/jamapsychiatry.2013.266","volume":"70","author":"HE Volk","year":"2013","unstructured":"Volk HE, Lurmann F, Penfold B, Hertz-Picciotto I, McConnell R. Traffic-related air pollution, particulate matter, and autism. JAMA Psychiatry. 2013;70(1):71\u20137.","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"564_CR19","first-page":"17","volume":"17","author":"S Yee","year":"1996","unstructured":"Yee S, Choi BH. Oxidative stress in neurotoxic effects of methylmercury poisoning. Neurotoxicology. 1996;17(1):17\u201326.","journal-title":"Neurotoxicology"},{"issue":"11","key":"564_CR20","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1046\/j.1440-1681.1999.03157.x","volume":"26","author":"SJ Flora","year":"1999","unstructured":"Flora SJ. Arsenic-induced oxidative stress and its reversibility following combined administration of N-acetylcysteine and meso 2,3-dimercaptosuccinic acid in rats. Clin Exp Pharmacol Physiol. 1999;26(11):865\u20139.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"564_CR21","first-page":"OL543","volume":"50","author":"SJS Flora","year":"2004","unstructured":"Flora SJS, Pande M, Kannan GM, Mehta A. Lead induced oxidative stress and its recovery following co-administration of melatonin or N-acetylcysteine during chelation with succimer in male rats. Cell Mol Biol. 2004;50:OL543\u201351.","journal-title":"Cell Mol Biol"},{"issue":"10","key":"564_CR22","doi-asserted-by":"crossref","first-page":"5582","DOI":"10.4049\/jimmunol.163.10.5582","volume":"163","author":"TS Hiura","year":"1999","unstructured":"Hiura TS, Kaszubowski MP, Li N, Nel AE. Chemicals in diesel exhaust particles generate reactive oxygen radicals and induce apoptosis in macrophages. J Immunol. 1999;163(10):5582\u201391.","journal-title":"J Immunol"},{"issue":"2","key":"564_CR23","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10565-006-0135-8","volume":"23","author":"S Bhadauria","year":"2007","unstructured":"Bhadauria S, Flora SJS. Response of arsenic-induced oxidative stress, DNA damage, and metal imbalance to combined administration of DMSA and monoisoamyl-DMSA during chronic arsenic poisoning in rats. Cell Biol Toxicol. 2007;23(2):91\u2013104.","journal-title":"Cell Biol Toxicol"},{"key":"564_CR24","first-page":"221","volume":"20","author":"I Sterzl","year":"1999","unstructured":"Sterzl I, Prochazkova J, Hrda P, Bartova J, Matucha P, Stejskal VDM. Mercury and nickel allergy: risk factors in fatigue and autoimmunity. Neuroendocrinol Lett. 1999;20:221\u20138.","journal-title":"Neuroendocrinol Lett"},{"key":"564_CR25","doi-asserted-by":"crossref","unstructured":"Kempuraj D, Asadi S, Zhang B, Manola A, Hoga J, Peterso E, et al. Mercury induces inflammatory mediator release from human mast cells. Journal of Neuroinflammation 2010, 7(20).","DOI":"10.1186\/1742-2094-7-20"},{"issue":"6","key":"564_CR26","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1080\/01926230490520232","volume":"32","author":"L Calderon-Garciduenas","year":"2004","unstructured":"Calderon-Garciduenas L, Reed W, Maronpot RR, Henriquez-Roldan C, Delgado-Chavez R, Calderon-Garciduenas A, et al. Brain inflammation and Alzheimer\u2019s-like pathology in individuals exposed to severe air pollution. Toxicol Pathol. 2004;32(6):650\u20138.","journal-title":"Toxicol Pathol"},{"issue":"5","key":"564_CR27","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.autrev.2004.12.001","volume":"4","author":"S Havarinasab","year":"2005","unstructured":"Havarinasab S, Hultman P. Organic mercury compounds and autoimmunity. Autoimmun Rev. 2005;4(5):270\u20135.","journal-title":"Autoimmun Rev"},{"issue":"2","key":"564_CR28","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/0192623307313011","volume":"36","author":"L Calderon-Garciduenas","year":"2008","unstructured":"Calderon-Garciduenas L, Solt AC, Henriquez-Roldan C, Torres-Jardon R, Nuse B, Herritt L, et al. Long-term Air pollution exposure is associated with neuroinflammation, an altered innate immune response, disruption of the blood\u2013brain barrier, ultrafine particulate deposition, and accumulation of amyloid \u03b2-42 and \u03b1-synuclein in children and young adults. Toxicol Pathol. 2008;36(2):289\u2013310.","journal-title":"Toxicol Pathol"},{"key":"564_CR29","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/mp.2010.136","volume":"17","author":"DA Rossignol","year":"2012","unstructured":"Rossignol DA, Frye RE. Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis. Mol Psychiatry. 2012;17:290\u2013314.","journal-title":"Mol Psychiatry"},{"key":"564_CR30","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/mp.2011.165","volume":"17","author":"DA Rossignol","year":"2012","unstructured":"Rossignol DA, Frye RE. A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures. Mol Psychiatry. 2012;17:389\u2013401.","journal-title":"Mol Psychiatry"},{"issue":"532640","key":"564_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2009\/532640","volume":"2009","author":"JB Adams","year":"2009","unstructured":"Adams JB, Baral M, Geis E, Mitchell J, Ingram J, Hensley A, et al. The severity of autism is associated with toxic metal body burden and red blood cell glutathione levels. J Toxicol. 2009;2009(532640):1\u20137.","journal-title":"J Toxicol"},{"issue":"1","key":"564_CR32","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.taap.2007.10.010","volume":"227","author":"J Stringari","year":"2008","unstructured":"Stringari J, Nunes AKC, Franco JL, Bohrer D, Garcia SC, Dafre AL, et al. Prenatal methylmercury exposure hampers glutathione antioxidant system ontogenesis and causes long-lasting oxidative stress in the mouse brain. Toxicol Appl Pharmacol. 2008;227(1):147\u201354.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"2","key":"564_CR33","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s11064-008-9782-x","volume":"34","author":"DA Geier","year":"2009","unstructured":"Geier DA, Kern JK, Garver CR, Adams JB, Audhya T, Geier MR. A prospective study of transsulfuration biomarkers in autistic disorders. Neurochem Res. 2009;34(2):386\u201393.","journal-title":"Neurochem Res"},{"issue":"1","key":"564_CR34","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.rasd.2010.04.010","volume":"5","author":"L Vergani","year":"2011","unstructured":"Vergani L, Cristina L, Paola R, Luisa AM, Shyti G, Edvige V, et al. Metals, metallothioneins and oxidative stress in blood of autistic children. Res Autism Spectr Disord. 2011;5(1):286\u201393.","journal-title":"Res Autism Spectr Disord"},{"key":"564_CR35","volume-title":"Metallothionein and autism [monograph]","author":"WJ Walsh","year":"2002","unstructured":"Walsh WJ, Usman A, Tarpey J, Kelly T. Metallothionein and autism [monograph]. 2nd ed. Naperville, IL: Pfeiffer Treatment Center; 2002.","edition":"2"},{"issue":"3","key":"564_CR36","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1006\/bbrc.1998.9026","volume":"248","author":"C Jacob","year":"1998","unstructured":"Jacob C, Maret W, Vallee BL. Ebselen, a selenium-containing redox drug, releases zinc from metallothionein. Biochem Biophys Res Commun. 1998;248(3):569\u201373.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"564_CR37","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.pathophys.2006.05.007","volume":"13","author":"A Chauhan","year":"2006","unstructured":"Chauhan A, Chauhan V. Oxidative stress in autism. Pathophysiology. 2006;13(3):171\u201381.","journal-title":"Pathophysiology"},{"issue":"6","key":"564_CR38","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1093\/ajcn\/80.6.1611","volume":"80","author":"SJ James","year":"2004","unstructured":"James SJ, Cutler P, Melnyk S, Jernigan S, Janak L, Gaylor DW, et al. Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am J Clin Nutr. 2004;80(6):1611\u20137.","journal-title":"Am J Clin Nutr"},{"issue":"8","key":"564_CR39","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/ajmg.b.30366","volume":"141B","author":"SJ James","year":"2006","unstructured":"James SJ, Melnyk S, Jernigan S, Cleves MA, Halsted CH, Wong DH, et al. Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism. Am J Med Genet B Neuropsychiatr Genet. 2006;141B(8):947\u201356.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"10","key":"564_CR40","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1096\/fasebj.10.10.8751715","volume":"10","author":"M Aschner","year":"1996","unstructured":"Aschner M. The functional significance of brain metallothioneins. FASEB J. 1996;10(10):1129\u201336.","journal-title":"FASEB J"},{"issue":"3","key":"564_CR41","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/13547500902783747","volume":"14","author":"S Faber","year":"2009","unstructured":"Faber S, Zinn GM, Kern II JC, Kingston HMS. The plasma zinc\/serum copper ratio as a biomarker in children with autism spectrum disorders. Biomarkers. 2009;14(3):171\u201380.","journal-title":"Biomarkers"},{"issue":"1\u20132","key":"564_CR42","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jneuroim.2008.09.005","volume":"205","author":"A Vojdani","year":"2008","unstructured":"Vojdani A, Mumper E, Granpeesheh D, Mielke L, Traver D, Bock K, et al. Low natural killer cell cytotoxic activity in autism: the role of glutathione, IL-2 and IL-15. J Neuroimmunol. 2008;205(1\u20132):148\u201354.","journal-title":"J Neuroimmunol"},{"issue":"3","key":"564_CR43","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/039463200301600302","volume":"16","author":"A Vojdani","year":"2003","unstructured":"Vojdani A, Pangborn JB, Vojdani E, Cooper EL. Infections, toxic chemicals and dietary peptides binding to lymphocyte receptors and tissue enzymes are major instigators of autoimmunity in autism. Int J Immunopathol Pharmacol. 2003;16(3):189\u201399.","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"3","key":"564_CR44","first-page":"148","volume":"21","author":"VK Singh","year":"2009","unstructured":"Singh VK. Phenotypic expression of autoimmune autistic disorder (AAD): a major subset of autism. Ann Clin Psychiatry. 2009;21(3):148\u201361.","journal-title":"Ann Clin Psychiatry"},{"issue":"1","key":"564_CR45","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/ana.20315","volume":"57","author":"DL Vargas","year":"2005","unstructured":"Vargas DL, Nascimbene C, Krishnan C, Zimmerman AW, Pardo CA. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol. 2005;57(1):67\u201381.","journal-title":"Ann Neurol"},{"issue":"3","key":"564_CR46","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.biopsych.2006.08.004","volume":"62","author":"RK Kana","year":"2007","unstructured":"Kana RK, Keller TA, Minshew NJ, Just MA. Inhibitory control in high-functioning autism: decreased activation and underconnectivity in inhibition networks. Biol Psychiatry. 2007;62(3):198\u2013206.","journal-title":"Biol Psychiatry"},{"key":"564_CR47","first-page":"371","volume-title":"The neurobiology of autism","author":"AW Zimmerman","year":"2005","unstructured":"Zimmerman AW. The immune system. In: Bauman ML, Kemper TL, editors. The neurobiology of autism. 2nd ed. Baltimore: The Johns Hopkins University Press; 2005. p. 371\u201386.","edition":"2"},{"issue":"1","key":"564_CR48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1189\/jlb.1205707","volume":"80","author":"P Ashwood","year":"2006","unstructured":"Ashwood P, Wills S, Van De Water J. The immune response in autism: a new frontier for autism research. J Leukoc Biol. 2006;80(1):1\u201315.","journal-title":"J Leukoc Biol"},{"issue":"4","key":"564_CR49","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/BF02172828","volume":"26","author":"S Gupta","year":"1996","unstructured":"Gupta S, Aggarwal S, Heads C. Brief report: dysregulated immune system in children with autism: beneficial effects of intravenous immune globulin on autistic characteristics. J Autism Dev Disord. 1996;26(4):439\u201352.","journal-title":"J Autism Dev Disord"},{"issue":"1","key":"564_CR50","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/BF02276236","volume":"26","author":"DR Denney","year":"1996","unstructured":"Denney DR, Frei BW, Gaffney GR. Lymphocyte subsets and interleukin-2 receptors in autistic children. J Autism Dev Disord. 1996;26(1):87\u201397.","journal-title":"J Autism Dev Disord"},{"key":"564_CR51","volume-title":"Pediatric Academic Societies' Annual Meeting: May 5\u20138 2007; Toronto, Canada","author":"S Faber","year":"2007","unstructured":"Faber S, Kobelak C, Caminos C. Immune dysregulation in a cohort of children with autism spectrum disorders. In: Pediatric Academic Societies' Annual Meeting: May 5\u20138 2007; Toronto, Canada. 2007."},{"issue":"1","key":"564_CR52","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.bbi.2010.08.003","volume":"25","author":"P Ashwood","year":"2011","unstructured":"Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah I, Van De Water J. Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain Behav Immun. 2011;25(1):40\u20135.","journal-title":"Brain Behav Immun"},{"issue":"6","key":"564_CR53","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1080\/02646830500381930","volume":"17","author":"CA Pardo","year":"2005","unstructured":"Pardo CA, Vargas DL, Zimmerman AW. Immunity, neuroglia and neuroinflammation in autism. Int Rev Psychiatry. 2005;17(6):485\u201395.","journal-title":"Int Rev Psychiatry"},{"key":"564_CR54","volume-title":"International Meeting for Autism Research: May 17\u201319 2012; Toronto, Canada","author":"S Faber","year":"2012","unstructured":"Faber S, Zinn GM, Fahrenholz T, Boggess A, Kern JC, Kingston HMS. A comparison study of inorganic and organic compounds in children with autism and controls. In: International Meeting for Autism Research: May 17\u201319 2012; Toronto, Canada. 2012."},{"issue":"S-2","key":"564_CR55","first-page":"445","volume":"105","author":"CS Miller","year":"1997","unstructured":"Miller CS. Toxicant-induced loss of tolerance-an emerging theory of disease. Environ Health Perspect. 1997;105(S-2):445\u201353.","journal-title":"Environ Health Perspect"},{"issue":"5","key":"564_CR56","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1067\/mai.2000.110548","volume":"106","author":"TAE Platts-Mills","year":"2000","unstructured":"Platts-Mills TAE, Vaughan JW, Carter MC, Woodfolk JA. The role of intervention in established allergy: avoidance of indoor allergens in the treatment of chronic allergic disease. J Allergy Clin Immunol. 2000;106(5):787\u2013804.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"564_CR57","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/0091-6749(92)90370-H","volume":"89","author":"T Sanda","year":"1992","unstructured":"Sanda T, Yasue T, Oohash M, Yasue A. Effectiveness of house dust-mite allergens avoidance through clean room therapy in patients with atopic dermatitis. J Allergy Clin Immunol. 1992;89(3):653\u20137.","journal-title":"J Allergy Clin Immunol"},{"key":"564_CR58","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1100\/tsw.2003.98","volume":"3","author":"EC Anyanwu","year":"2003","unstructured":"Anyanwu EC, Campbell AW, Jones J, Ehiri J. The neurological significance of abnormal natural killer cell activity in chronic toxigenic mold exposures. Sci World J. 2003;3:1128\u201337.","journal-title":"Sci World J"},{"key":"564_CR59","doi-asserted-by":"crossref","unstructured":"Theoharides TC, Zhang B. Neuro-inflammation, blood\u2013brain barrier, seizures and autism. Journal of Neuroinflammation 2011;8(168).","DOI":"10.1186\/1742-2094-8-168"},{"key":"564_CR60","volume-title":"Seminar for environmental avoidance strategies in severe autism: March 13\u201314 2002; Jackson, Michigan","author":"KM Slimak","year":"2002","unstructured":"Slimak KM. Autistic symptoms caused by chemicals in food, indoor air and mold; and using avoidance strategies to eliminate symptoms in children suffering from severe autism. In: Seminar for environmental avoidance strategies in severe autism: March 13\u201314 2002; Jackson, Michigan. 2002."},{"key":"564_CR61","volume-title":"Second International Conference on Advances in Treatment of Autistic Spectrum Disorders, Opening Doors--New Biological Treatment Alternatives, Sociedad Venezolana para Ni\u00f1os y Adultos Autistas (SOVENIA): February 15\u201316 2002; Caracus, Venezuela","author":"KM Slimak","year":"2002","unstructured":"Slimak KM. In 45 autistic children sharp decreases in autistic symptoms follow elimination of problem foods, volatile organic compounds, plastics, resins, and molds. In: Second International Conference on Advances in Treatment of Autistic Spectrum Disorders, Opening Doors--New Biological Treatment Alternatives, Sociedad Venezolana para Ni\u00f1os y Adultos Autistas (SOVENIA): February 15\u201316 2002; Caracus, Venezuela. 2002."},{"key":"564_CR62","volume-title":"Annual Conference of the Association for Science in the Public Interest: May 31-June 2 2001; Virginia Commonwealth University, Richmond, Virginia","author":"KM Slimak","year":"2001","unstructured":"Slimak KM. Effect of removal of low levels of volatile organic compounds on severe autistic behaviors in children. In: Annual Conference of the Association for Science in the Public Interest: May 31-June 2 2001; Virginia Commonwealth University, Richmond, Virginia. 2001."},{"key":"564_CR63","first-page":"206","volume-title":"Proceedings of 2003 International Symposium on Indoor Air Quality and Health Hazards. vol. 2. Tokyo, Japan","author":"KM Slimak","year":"2003","unstructured":"Slimak KM. Reduction of autistic traits following dietary intervention and elimination of exposure to environmental substances. In: Proceedings of 2003 International Symposium on Indoor Air Quality and Health Hazards. vol. 2. Tokyo, Japan. 2003. p. 206\u201316."},{"issue":"2","key":"564_CR64","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/BF02172020","volume":"26","author":"SJ Rogers","year":"1996","unstructured":"Rogers SJ. Brief report: early intervention in autism. J Autism Dev Disord. 1996;26(2):243\u20136.","journal-title":"J Autism Dev Disord"},{"issue":"10","key":"564_CR65","doi-asserted-by":"crossref","first-page":"677","DOI":"10.3928\/0090-4481-20031001-09","volume":"32","author":"EM Butter","year":"2003","unstructured":"Butter EM, Wynn J, Mulick JA. Early intervention critical to autism treatment. Pediatr Ann. 2003;32(10):677\u201384.","journal-title":"Pediatr Ann"},{"issue":"3","key":"564_CR66","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/mrdd.20072","volume":"11","author":"T Dumont-Mathieu","year":"2005","unstructured":"Dumont-Mathieu T, Fein D. Screening for Autism in Young Children: The Modified Checklist for Autism in Toddlers (M-CHAT) and Other Measures. Ment Retard Dev Disabil Res Rev. 2005;11(3):253\u201362.","journal-title":"Ment Retard Dev Disabil Res Rev"},{"key":"564_CR67","volume-title":"Autism diagnostic observation schedule","author":"C Lord","year":"1999","unstructured":"Lord C, Rutter M, DiLavore PC, Risi S. Autism diagnostic observation schedule. Los Angeles, CA: Western Psychological Services; 1999."},{"key":"564_CR68","volume-title":"Cleanrooms and associated controlled environments--Part 1: Classification of air cleanliness","author":"International Organization of Standardization","year":"1999","unstructured":"International Organization of Standardization. Cleanrooms and associated controlled environments--Part 1: Classification of air cleanliness. Switzerland: International Organization of Standardization; 1999."},{"key":"564_CR69","volume-title":"Microwave assisted acid digestion of siliceous and organically based matrices in test methods for evaluating solid waste, physical\/chemical methods SW-846","author":"U.S. EPA Method 3052","year":"1996","unstructured":"U.S. EPA Method 3052. Microwave assisted acid digestion of siliceous and organically based matrices in test methods for evaluating solid waste, physical\/chemical methods SW-846. Washington, D.C: U.S. Government Printing Office; 1996."},{"key":"564_CR70","volume-title":"Inductively coupled plasma-mass spectrometry in test methods for evaluating solid waste, physical\/chemical methods SW-846","author":"U.S. EPA Method 6020B","year":"2013","unstructured":"U.S. EPA Method 6020B. Inductively coupled plasma-mass spectrometry in test methods for evaluating solid waste, physical\/chemical methods SW-846. Washington, D.C: U.S. Government Printing Office; 2013."},{"key":"564_CR71","first-page":"1","volume-title":"vol. Update IVA","author":"U.S. EPA Method 6800","year":"2007","unstructured":"U.S. EPA Method 6800. Elemental and speciated isotope dilution mass spectrometry in test methods for evaluating solid waste, physical\/chemical methods SW-846. In: vol. Update IVA. Washington, D.C: U.S. Government Printing Office; 2007. p. 1\u201347."},{"key":"564_CR72","volume-title":"Volatile organic compounds by isotope dilution GCMS","author":"U.S. EPA Method 1624","year":"1989","unstructured":"U.S. EPA Method 1624. Volatile organic compounds by isotope dilution GCMS. Washington, D.C: U.S. Government Printing Office; 1989."},{"key":"564_CR73","volume-title":"Semivolatile organic compounds by isotope dilution GCMS","author":"U.S. EPA Method 1625","year":"1989","unstructured":"U.S. EPA Method 1625. Semivolatile organic compounds by isotope dilution GCMS. Washington, D.C: U.S. Government Printing Office; 1989."},{"key":"564_CR74","volume-title":"Social communication questionnaire","author":"M Rutter","year":"2003","unstructured":"Rutter M, Bailey A, Lord C. Social communication questionnaire. Los Angeles, CA: Western Psychological Services; 2003."},{"key":"564_CR75","volume-title":"PDD behavior inventory","author":"IL Cohen","year":"2005","unstructured":"Cohen IL, Sudhalter V. PDD behavior inventory. Lutz, FL: Psychological Assessment Resources; 2005."},{"issue":"5","key":"564_CR76","first-page":"485","volume":"89","author":"MG Aman","year":"1985","unstructured":"Aman MG, Singh NN, Stewart AW, Field CJ. The aberrant behavior checklist: a behavior rating scale for the assessment of the treatment effects. Am J Ment Defic. 1985;89(5):485\u201391.","journal-title":"Am J Ment Defic"},{"key":"564_CR77","volume-title":"Gilliam autism rating scale-second edition","author":"JE Gilliam","year":"2006","unstructured":"Gilliam JE. Gilliam autism rating scale-second edition. Austin, TX: ProEd; 2006."},{"key":"564_CR78","volume-title":"Autism treatment evaluation checklist","author":"B Rimland","year":"1999","unstructured":"Rimland B, Edelson M. Autism treatment evaluation checklist. San Diego, CA: Autism Research Institute; 1999."},{"key":"564_CR79","volume-title":"The Childhood Autism Rating Scale (CARS): for diagnostic screening and classification of autism","author":"E Schopler","year":"1986","unstructured":"Schopler E, Reichler RJ, Rochen Renner B. The Childhood Autism Rating Scale (CARS): for diagnostic screening and classification of autism. Irvington, New York: Irvington Press; 1986."},{"issue":"5","key":"564_CR80","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1192\/bjp.175.5.444","volume":"175","author":"SK Berument","year":"1999","unstructured":"Berument SK, Rutter M, Lord C, Pickles A, Bailey A. Autism screening questionnaire: diagnostic validity. Br J Psychiatry. 1999;175(5):444\u201351.","journal-title":"Br J Psychiatry"},{"issue":"1","key":"564_CR81","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1023\/A:1022226403878","volume":"33","author":"IL Cohen","year":"2003","unstructured":"Cohen IL, Schmidt-Lackner S, Romanczyk R, Sudhalter V. The PDD behavior inventory: a rating scale for assessing response to intervention in children with pervasive developmental disorder. J Autism Dev Disord. 2003;33(1):31\u201345.","journal-title":"J Autism Dev Disord"},{"key":"564_CR82","volume-title":"The application of mass spectrometric measurement techniques for the evaluation and assessment of autism spectrum disorders","author":"GM Zinn","year":"2014","unstructured":"Zinn GM. The application of mass spectrometric measurement techniques for the evaluation and assessment of autism spectrum disorders. Pittsburgh, PA: Duquesne University; 2014."},{"key":"564_CR83","unstructured":"Fourth National Report on Human Exposure to Environmental Chemicals www.cdc.gov\/exposurereport\/"},{"key":"564_CR84","doi-asserted-by":"crossref","unstructured":"Adams JB, Baral M, Geis E, Mitchell J, Ingram J, Hensley A, et al. Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: Part A - Medical results. BMC Clinical Pharmacology 2009, 9(16).","DOI":"10.1186\/1472-6904-9-16"},{"issue":"11","key":"564_CR85","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0891-5849(01)00480-4","volume":"30","author":"FQ Schafer","year":"2001","unstructured":"Schafer FQ, Buettner GR. Redox envionment of the cell as viewed through the redox state of the glutathione disulfide\/glutathione couple. Free Radic Biol Med. 2001;30(11):1191\u2013212.","journal-title":"Free Radic Biol Med"},{"issue":"1\u20132","key":"564_CR86","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jns.2008.08.021","volume":"280","author":"DA Geier","year":"2009","unstructured":"Geier DA, Kern JK, Garver CR, Adams JB, Audhya T, Nataf R, et al. Biomarkers of environmental toxicity and susceptibility in autism. J Neurol Sci. 2009;280(1\u20132):101\u20138.","journal-title":"J Neurol Sci"},{"issue":"1\u20132","key":"564_CR87","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.mrfmmm.2003.11.003","volume":"546","author":"Y Wu","year":"2004","unstructured":"Wu Y, Zheng J, Linden J, Holoshitz J. Genoprotective pathways part I. Extracellular signaling through Gs protein-coupled adenosine receptors prevents oxidative DNA damage. Mutat Res-Fund Mol M. 2004;546(1\u20132):93\u2013102.","journal-title":"Mutat Res-Fund Mol M"},{"issue":"2","key":"564_CR88","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0304-3940(02)01478-7","volume":"339","author":"CG Almeida","year":"2003","unstructured":"Almeida CG, de Mendonca A, Cunha RA, Ribeiro JA. Adenosine promotes neuronal recovery from reactive oxygen species induced lesion in rat hippocampal slices. Neurosci Lett. 2003;339(2):127\u201330.","journal-title":"Neurosci Lett"},{"issue":"5","key":"564_CR89","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.bpj.2009.11.009","volume":"98","author":"N Chakrabarti","year":"2010","unstructured":"Chakrabarti N, Neale C, Payandeh J, Pai EF, Pomes R. An iris-like mechanism of pore dilation in the CorA magnesium transport system. Biophys J. 2010;98(5):784\u201392.","journal-title":"Biophys J"},{"issue":"2","key":"564_CR90","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1385\/BTER:109:2:097","volume":"109","author":"M Strambi","year":"2006","unstructured":"Strambi M, Longini M, Hayek J, Berni S, Macucci F, Scalacci E, et al. Magnesium profile in autism. Biol Trace Elem Res. 2006;109(2):97\u2013104.","journal-title":"Biol Trace Elem Res"},{"issue":"2","key":"564_CR91","doi-asserted-by":"crossref","first-page":"72","DOI":"10.5414\/TEP26072","volume":"26","author":"A Lubkowska","year":"2009","unstructured":"Lubkowska A, Sobieraj W. Concentrations of magnesium, calcium, iron, selenium, zinc, and copper in the hair of autistic children. Trace Elem Electrolytes. 2009;26(2):72\u20137.","journal-title":"Trace Elem Electrolytes"},{"issue":"1","key":"564_CR92","first-page":"53","volume":"19","author":"M Mousain-Bosc","year":"2006","unstructured":"Mousain-Bosc M, Roche M, Polge A, Pradal-Prat D, Rapin J, Bali JP. Improvement of neurobehavioral disorders in children supplemented with magnesium-vitamin B6 II. Pervasive developmental disorder-autism. Magnes Res. 2006;19(1):53\u201362.","journal-title":"Magnes Res"},{"issue":"1","key":"564_CR93","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1089\/acm.2007.0610","volume":"14","author":"LT Curtis","year":"2008","unstructured":"Curtis LT, Patel K. Nutritional and environmental approaches to preventing and treating autism and attention deficit hyperactivity disorder (ADHD): a review. J Altern Complement Med. 2008;14(1):79\u201385.","journal-title":"J Altern Complement Med"},{"key":"564_CR94","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.microc.2012.12.013","volume":"108","author":"J Marrero","year":"2013","unstructured":"Marrero J, Rebagliati RJ, Leiva E, Londonio A, Smichowski P. Inductively coupled plasma optical emission spectrometric determination of fifteen elements in dietary supplements: are the concentrations declared in the labels accurate? Microchem J. 2013;108:81\u20136.","journal-title":"Microchem J"},{"issue":"1","key":"564_CR95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0029665110003873","volume":"70","author":"SJ Fairweather-Tait","year":"2011","unstructured":"Fairweather-Tait SJ, Harvey LJ, Collings R. Risk-benefit analysis of mineral intakes: case studies on copper and iron. Proc Nutr Soc. 2011;70(1):1\u20139.","journal-title":"Proc Nutr Soc"},{"issue":"7","key":"564_CR96","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1073\/pnas.95.7.3483","volume":"95","author":"L-J Jiang","year":"1998","unstructured":"Jiang L-J, Maret W, Vallee BL. The glutathione redox couple modulates zinc transfer from metallothionein to zinc-depleted sorbitol dehydrogenase. Proc Natl Acad Sci U S A. 1998;95(7):3483\u20138.","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["BMC Complementary and Alternative Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12906-015-0564-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-015-0564-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-015-0564-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-015-0564-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T21:35:39Z","timestamp":1691530539000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-015-0564-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,19]]},"references-count":96,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["564"],"URL":"https:\/\/doi.org\/10.1186\/s12906-015-0564-0","relation":{},"ISSN":["1472-6882"],"issn-type":[{"value":"1472-6882","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,19]]},"assertion":[{"value":"20 May 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"71"}}